M&A

• Danish biotech Genmab agreed to acquire Dutch cancer drugmaker Merus for $8B cash at a 40% premium  Bloomberg

  
  

• UChicago will sell its Center for Research in Security Prices for $375M to shore up its endowment  Bloomberg

  
  

• Chinese tech giant ByteDance will retain ownership of TikTok's US business operations in the $14B US-China deal  CNBC

  
  

• Occidental Petroleum is in talks to sell its OxyChem petrochemical unit for $10B Financial Times 

  
  

• TA Associates-backed MRI Software is weighing a sale or IPO at a $10B valuation  Bloomberg

  
  

• Swiss nutrition products firm DSM-Firmenich re-invited Apollo to join bidding against CVC for its animal nutrition and health unit, which could fetch $3.2B  Bloomberg

  
  

• South Korea's DB Insurance agreed to acquire US specialty insurer Fortegra Group for $1.65B  Yahoo.Finance

  
  

• Dutch tech investor Prosus-backed OLX Group will buy French online auto trader La Centrale for $1.3B cash  Reuters

  
  

• UK energy supplier Ovo Energy is exploring a stake sale in software spinout Kaluza at a $1B valuation  Bloomberg

  
  

• Pharma giant Abbott Laboratories will acquire several assets of New Zealand's Synlait Milk for $177M   Yahoo.Finance

  
  

• Media broadcasting group MFE-MediaForEurope is in talks to acquire a stake in Portuguese media company Impresa  Reuters

  
  

• Danish biotech Genmab is in advanced talks to acquire Dutch cancer drugmaker Merus  Reuters